Skip to main content

Advertisement

Log in

Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Agonist medications have been proven effective in treating opioid and nicotine dependence; results from clinical studies suggest that the indirect dopamine agonist d-amphetamine may reduce cocaine abuse. In preclinical studies, chronic d-amphetamine treatment decreased ongoing cocaine self-administration.

Objectives

The present study extended previous results by determining effects of chronic d-amphetamine treatment on the reinforcing strength of cocaine under conditions in which access to cocaine was suspended during d-amphetamine treatment.

Methods

Daily operant conditioning sessions consisted of morning access to food pellets delivered under a 50-response fixed-ratio schedule and evening access to cocaine (0.005–0.48 mg/kg per injection, i.v.) under a progressive-ratio schedule. After responding maintained by 0.045 mg/kg per injection cocaine stabilized, self-administration sessions were suspended and d-amphetamine (0.01–0.1 mg/kg per hr, i.v.) was administered continuously for 5 days. On the following day, d-amphetamine treatment was discontinued and daily self-administration sessions resumed.

Results

Following termination of d-amphetamine treatment, food- and cocaine-maintained responding was decreased in a dose-related manner. Decreases in the reinforcing strength of cocaine were larger and lasted longer than effects on food reinforcement. However, cocaine self-administration was unaltered if 6 days elapsed between discontinuation of d-amphetamine treatment and the next cocaine self-administration session.

Conclusions

The necessity of a self-administration session in the presence of d-amphetamine suggests that the protracted decrease in cocaine self-administration may be a manifestation of behavioral tolerance. Regarding treatment of cocaine dependence, data suggest that prolonged d-amphetamine treatment may be necessary to produce a sustained reduction in the reinforcing effects of cocaine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ator NA, Griffiths RR (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 5:S55–S72

    Article  CAS  Google Scholar 

  • Barrett AC, Miller JR, Dohrmann JM, Caine SB (2004) Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropsychopharmacology 47(Suppl 1):256–273

    CAS  Google Scholar 

  • Beckett AH, Rowland M (1965) Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol 17:628–639

    CAS  PubMed  Google Scholar 

  • Carroll FI, Howell LL, Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42:2721–2736

    Article  CAS  PubMed  Google Scholar 

  • Castells X, Casas M, Vidal X, Bosch R, Roncero C, Ramos-Quiroga JA, Capella D (2007) Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials. Addiction 102:1871–1887

    Article  PubMed  Google Scholar 

  • Charnaud B, Griffiths V (1998) Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug Alcohol Depend 52:79–84

    Article  CAS  PubMed  Google Scholar 

  • Chiodo KA, Roberts DC (2009) Decreased reinforcing effects of cocaine following 2 weeks of continuous d-amphetamine treatment in rats. Psychopharmacology 206:447–456

    Article  CAS  PubMed  Google Scholar 

  • Chiodo KA, Lack CM, Roberts DC (2008) Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology 200:465–473

    Article  CAS  PubMed  Google Scholar 

  • Czoty PW, Martelle JL, Nader MA (2006) Influence of abstinence and conditions of cocaine access on the reinforcing strength of cocaine in nonhuman primates. Drug Alcohol Depend 85:213–220

    Article  CAS  PubMed  Google Scholar 

  • de Wit H, Stewart J (1983) Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology 79:29–31

    Article  PubMed  Google Scholar 

  • Fleming PM, Roberts D (1994) Is the prescription of amphetamine justified as a harm reduction measure? J R Soc Health 114:127–131

    Article  CAS  PubMed  Google Scholar 

  • Foltin RW, Evans SM (1999) The effects of d-amphetamine on intake of food and a sweet fluid containing cocaine. Pharmacol Biochem Behav 62:457–464

    Article  CAS  PubMed  Google Scholar 

  • Gerber GJ, Stretch R (1975) Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol Biochem Behav 3:1055–1061

    Article  CAS  PubMed  Google Scholar 

  • Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FG (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacology 21:522–526

    Article  CAS  Google Scholar 

  • Grabowski J, Shearer J, Merrill J, Negus SS (2004a) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439–1464

    Article  PubMed  Google Scholar 

  • Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J (2004b) Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29:969–981

    Article  CAS  PubMed  Google Scholar 

  • Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse, vol 1. JAI, Greenwich, pp 1–90

    Google Scholar 

  • Howell LL, Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1–6

    CAS  PubMed  Google Scholar 

  • Kreek MJ (2000) Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 909:186–216

    Article  CAS  PubMed  Google Scholar 

  • Lile JA, Nader MA (2003) The abuse liability and therapeutic potential of drugs evaluated for cocaine addiction as predicted by animal models. Curr Neuropharmacol 1:21–46

    Article  CAS  Google Scholar 

  • Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, Nader MA (2003) The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. J Pharmacol Exp Ther 307:356–366

    Article  CAS  PubMed  Google Scholar 

  • Mansbach RS, Balster RL (1993) Effects of mazindol on behavior maintained or occasioned by cocaine. Drug Alcohol Depend 31:183–191

    Article  CAS  PubMed  Google Scholar 

  • Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375–424

    Article  CAS  PubMed  Google Scholar 

  • Negus SS (2003) Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28:909–931

    Google Scholar 

  • Negus SS, Mello NK (2003a) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology 167:324–332

    CAS  PubMed  Google Scholar 

  • Negus SS, Mello NK (2003b) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70:39–52

    Article  CAS  PubMed  Google Scholar 

  • Negus SS, Mello NK, Blough BE, Baumann MH, Rothman RB (2007) Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate “agonist” medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320:627–636

    Article  CAS  PubMed  Google Scholar 

  • Platt DM, Rowlett JK, Spealman RD (2002) Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 163:265–282

    Article  CAS  PubMed  Google Scholar 

  • Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1–11

    Article  CAS  PubMed  Google Scholar 

  • Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, Roth BL, Baumann MH (2005) Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J Pharmacol Exp Ther 313:1361–1369

    Article  CAS  PubMed  Google Scholar 

  • Rush CR, Stoops WW, Hays LR (2009) Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend 99:261–271

    Article  CAS  PubMed  Google Scholar 

  • Shearer J (2008) The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev 27:301–308

    Article  PubMed  Google Scholar 

  • Shearer J, Wodak A, Mattick RP, van Beek I, Lewis J, Hall W, Dolan K (2001) Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction 96:1289–1296

    Article  CAS  PubMed  Google Scholar 

  • Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J (2003) Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98:1137–1141

    Article  PubMed  Google Scholar 

  • Silagy C, Lancaster T, Stead L, Many D, Fowler G (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3:CD000146

    PubMed  Google Scholar 

  • Vocci F, Ling W (2005) Medications development: successes and challenges. Pharmacol Ther 108:94–108

    Article  CAS  PubMed  Google Scholar 

  • White R (2000) Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction 95:229–238

    Article  CAS  PubMed  Google Scholar 

  • Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193–200

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Tonya Calhoun and Susan Nader for their assistance in completing these studies. This research was supported by NIDA grant P50 DA-06634. The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael A. Nader.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Czoty, P.W., Martelle, J.L. & Nader, M.A. Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys. Psychopharmacology 209, 375–382 (2010). https://doi.org/10.1007/s00213-010-1807-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-010-1807-x

Keywords

Navigation